Depressive Disorder clinical trials

Explore recruiting depressive disorder clinical trials.

Recruiting depressive disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Depressive Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II, 6-week, multi-centre, randomised, double-blind (participant and investigator), placebo-controlled, dose-finding trial to evaluate the efficacy, tolerability, and safety of different doses of oral BI 1569912 as adjunctive therapy in patients with major depressive disorder

Belgium, Bulgaria, Czechia, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

NBI-1065845-MDD3024: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of NBI-1065845 as Adjunctive Treatment in Subjects with Major Depressive Disorder (MDD)

Poland, Croatia, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Milsaperidone as Adjunctive Therapy in the Treatment of Patients with Major Depressive Disorder

Poland, Czechia, Bulgaria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Reward-specific changes of cerebral dopamine synthesis in healthy volunteers and depressed patients

Austria

Therapeutic use (Phase IV) EU CTIS Study details

EFFECTIVENESS OF SUPPLEMENTATION WITH VITAMIN D IN PATIENTS WITH DEPRESSIVE DISORDER OR BIPOLAR DISORDER: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Italy

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder

Spain, Czechia, Slovakia, Romania, Poland, Finland +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Depressive Disorder trials by city

Depressive Disorder in Toronto Depressive Disorder in Vancouver Depressive Disorder in Montreal Depressive Disorder in Calgary Depressive Disorder in Edmonton Depressive Disorder in Ottawa Depressive Disorder in Winnipeg Depressive Disorder in Quebec City Depressive Disorder in Hamilton Depressive Disorder in Kitchener Depressive Disorder in London Depressive Disorder in Halifax Depressive Disorder in New York Depressive Disorder in Los Angeles Depressive Disorder in Chicago Depressive Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease